Stocktoria
Reckitt Benckiser Group plc RKT.L
GB · London Stock Exchange · XLON · stock · Consumer Defensive · website
Reckitt Benckiser Group plc financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $14.2B | $14.2B | $14.6B | $14.5B |
| Gross profit | $8.6B | $8.6B | $8.8B | $8.4B |
| R&D expense | $316.0M | $325.0M | $337.0M | $325.0M |
| SG&A expense | $4.9B | $4.8B | $5.1B | $4.6B |
| Operating income | $3.4B | $3.4B | $3.3B | $3.4B |
| Interest expense | $423.0M | $393.0M | $309.0M | $233.0M |
| Income tax | $635.0M | $672.0M | $753.0M | $711.0M |
| Net income | $3.2B | $1.4B | $1.6B | $2.3B |
| EPS (diluted) | $4.87 | $2.12 | $2.38 | $3.38 |
| Operating cash flow | $2.3B | $2.7B | $2.6B | $2.4B |
| Free cash flow | $1.7B | $2.2B | $2.2B | $2.0B |
| Cash & equivalents | $1.8B | $760.0M | $1.2B | $881.0M |
| Inventory | $1.5B | $1.5B | $1.6B | $1.8B |
| Total assets | $25.1B | $25.3B | $27.1B | $28.7B |
| Total liabilities | $17.3B | $18.6B | $18.7B | $19.3B |
| Shareholders' equity | $7.7B | $6.7B | $8.4B | $9.4B |
Growth · year-over-year · Revenue CAGR -0.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +0.3% | -3.0% | +1.1% | — |
| Net income growth | +123.1% | -13.2% | -29.5% | — |
| EPS growth | +129.9% | -11.1% | -29.6% | — |
| Free cash flow growth | -24.1% | +1.4% | +11.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · GB · as of 2025-12-31. Figures in GBp; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.